Contineum
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Contineum and other ETFs, options, and stocks.About CTNM
Contineum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. The company was founded by Daniel S.
CEOCarmine N. Stengone
CEOCarmine N. Stengone
Employees41
Employees41
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2017
Founded2017
Employees41
Employees41
CTNM Key Statistics
Market cap357.89M
Market cap357.89M
Price-Earnings ratio-5.16
Price-Earnings ratio-5.16
Dividend yield—
Dividend yield—
Average volume269.17K
Average volume269.17K
High today$12.67
High today$12.67
Low today$11.50
Low today$11.50
Open price$12.20
Open price$12.20
Volume1.50M
Volume1.50M
52 Week high$15.25
52 Week high$15.25
52 Week low$3.35
52 Week low$3.35
Stock Snapshot
The current Contineum(CTNM) stock price is $11.63, with a market capitalization of 357.89M. The stock trades at a price-to-earnings (P/E) ratio of -5.16.
During the trading session on 2025-12-13, Contineum(CTNM) shares reached a daily high of $12.67 and a low of $11.50. At a current price of $11.63, the stock is +1.1% higher than the low and still -8.2% under the high.
Trading activity shows a volume of 1.5M, compared to an average daily volume of 269.17K.
The stock's 52-week range extends from a low of $3.35 to a high of $15.25.
The stock's 52-week range extends from a low of $3.35 to a high of $15.25.
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CTNM. This list is generated using Robinhood data, and it’s not a recommendation.